Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk: The cardiovascular health study

Joshua I. Barzilay, Petra Bůžková, Susan J. Zieman, Jorge Kizer, Luc Djoussé, Joachim H. Ix, Russell P. Tracy, David S. Siscovick, Jane A. Cauley, Kenneth J. Mukamal

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Advanced glycation end products (AGE) in bone tissue are associated with impaired biomechanical properties and increased fracture risk. Here we examine whether serum levels of the AGE carboxy-methyl-lysine (CML) are associated with risk of hip fracture. We followed 3373 participants from the Cardiovascular Health Study (age 78 years; range, 68-102 years; 39.8% male) for a median of 9.22 years (range, 0.01-12.07 years). Rates of incident hip fracture were calculated by quartiles of baseline CML levels, and hazard ratios were adjusted for covariates associated with hip fracture risk. A subcohort of 1315 participants had bone mineral density (BMD) measurement. There were 348 hip fractures during follow-up, with incidence rates of hip fracture by CML quartiles of 0.94, 1.34, 1.18, and 1.69 per 100 participant-years. The unadjusted hazard ratio of hip fracture increased with each 1 SD increase (189ng/mL) of CML level (hazard ratio, 1.27; 95% confidence interval [CI], 1.16-1.40]; p<0.001). Sequential adjustment for age, gender, race/ethnicity, body mass index (BMI), smoking, alcohol consumption, prevalent coronary heart disease (CHD), energy expenditure, and estimated glomerular filtration rate (based on cystatin C), moderately attenuated the hazard ratio for fracture (1.17; 95% CI, 1.05-1.31; p=0.006). In the cohort with BMD testing, total hip BMD was not significantly associated with CML levels. We conclude that increasing levels of CML are associated with hip fracture risk in older adults, independent of hip BMD. These results implicate AGE in the pathogenesis of hip fractures.

Original languageEnglish (US)
Pages (from-to)1061-1066
Number of pages6
JournalJournal of Bone and Mineral Research
Volume29
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Hip Fractures
Lysine
Health
Bone Density
Advanced Glycosylation End Products
Pelvic Bones
Confidence Intervals
Cystatin C
Glomerular Filtration Rate
Alcohol Drinking
Energy Metabolism
Coronary Disease
Body Mass Index
Smoking
Bone and Bones
Incidence
Serum

Keywords

  • bone mineral density
  • bone quality
  • carboxy-methyl-lysine
  • cardiovascular health study
  • hip fracture risk

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Barzilay, J. I., Bůžková, P., Zieman, S. J., Kizer, J., Djoussé, L., Ix, J. H., ... Mukamal, K. J. (2014). Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk: The cardiovascular health study. Journal of Bone and Mineral Research, 29(5), 1061-1066. https://doi.org/10.1002/jbmr.2123

Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk : The cardiovascular health study. / Barzilay, Joshua I.; Bůžková, Petra; Zieman, Susan J.; Kizer, Jorge; Djoussé, Luc; Ix, Joachim H.; Tracy, Russell P.; Siscovick, David S.; Cauley, Jane A.; Mukamal, Kenneth J.

In: Journal of Bone and Mineral Research, Vol. 29, No. 5, 2014, p. 1061-1066.

Research output: Contribution to journalArticle

Barzilay, JI, Bůžková, P, Zieman, SJ, Kizer, J, Djoussé, L, Ix, JH, Tracy, RP, Siscovick, DS, Cauley, JA & Mukamal, KJ 2014, 'Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk: The cardiovascular health study', Journal of Bone and Mineral Research, vol. 29, no. 5, pp. 1061-1066. https://doi.org/10.1002/jbmr.2123
Barzilay, Joshua I. ; Bůžková, Petra ; Zieman, Susan J. ; Kizer, Jorge ; Djoussé, Luc ; Ix, Joachim H. ; Tracy, Russell P. ; Siscovick, David S. ; Cauley, Jane A. ; Mukamal, Kenneth J. / Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk : The cardiovascular health study. In: Journal of Bone and Mineral Research. 2014 ; Vol. 29, No. 5. pp. 1061-1066.
@article{13cbe8cb86f94987a86d647d9394bc95,
title = "Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk: The cardiovascular health study",
abstract = "Advanced glycation end products (AGE) in bone tissue are associated with impaired biomechanical properties and increased fracture risk. Here we examine whether serum levels of the AGE carboxy-methyl-lysine (CML) are associated with risk of hip fracture. We followed 3373 participants from the Cardiovascular Health Study (age 78 years; range, 68-102 years; 39.8{\%} male) for a median of 9.22 years (range, 0.01-12.07 years). Rates of incident hip fracture were calculated by quartiles of baseline CML levels, and hazard ratios were adjusted for covariates associated with hip fracture risk. A subcohort of 1315 participants had bone mineral density (BMD) measurement. There were 348 hip fractures during follow-up, with incidence rates of hip fracture by CML quartiles of 0.94, 1.34, 1.18, and 1.69 per 100 participant-years. The unadjusted hazard ratio of hip fracture increased with each 1 SD increase (189ng/mL) of CML level (hazard ratio, 1.27; 95{\%} confidence interval [CI], 1.16-1.40]; p<0.001). Sequential adjustment for age, gender, race/ethnicity, body mass index (BMI), smoking, alcohol consumption, prevalent coronary heart disease (CHD), energy expenditure, and estimated glomerular filtration rate (based on cystatin C), moderately attenuated the hazard ratio for fracture (1.17; 95{\%} CI, 1.05-1.31; p=0.006). In the cohort with BMD testing, total hip BMD was not significantly associated with CML levels. We conclude that increasing levels of CML are associated with hip fracture risk in older adults, independent of hip BMD. These results implicate AGE in the pathogenesis of hip fractures.",
keywords = "bone mineral density, bone quality, carboxy-methyl-lysine, cardiovascular health study, hip fracture risk",
author = "Barzilay, {Joshua I.} and Petra Bůžkov{\'a} and Zieman, {Susan J.} and Jorge Kizer and Luc Djouss{\'e} and Ix, {Joachim H.} and Tracy, {Russell P.} and Siscovick, {David S.} and Cauley, {Jane A.} and Mukamal, {Kenneth J.}",
year = "2014",
doi = "10.1002/jbmr.2123",
language = "English (US)",
volume = "29",
pages = "1061--1066",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Circulating levels of carboxy-methyl-lysine (CML) are associated with hip fracture risk

T2 - The cardiovascular health study

AU - Barzilay, Joshua I.

AU - Bůžková, Petra

AU - Zieman, Susan J.

AU - Kizer, Jorge

AU - Djoussé, Luc

AU - Ix, Joachim H.

AU - Tracy, Russell P.

AU - Siscovick, David S.

AU - Cauley, Jane A.

AU - Mukamal, Kenneth J.

PY - 2014

Y1 - 2014

N2 - Advanced glycation end products (AGE) in bone tissue are associated with impaired biomechanical properties and increased fracture risk. Here we examine whether serum levels of the AGE carboxy-methyl-lysine (CML) are associated with risk of hip fracture. We followed 3373 participants from the Cardiovascular Health Study (age 78 years; range, 68-102 years; 39.8% male) for a median of 9.22 years (range, 0.01-12.07 years). Rates of incident hip fracture were calculated by quartiles of baseline CML levels, and hazard ratios were adjusted for covariates associated with hip fracture risk. A subcohort of 1315 participants had bone mineral density (BMD) measurement. There were 348 hip fractures during follow-up, with incidence rates of hip fracture by CML quartiles of 0.94, 1.34, 1.18, and 1.69 per 100 participant-years. The unadjusted hazard ratio of hip fracture increased with each 1 SD increase (189ng/mL) of CML level (hazard ratio, 1.27; 95% confidence interval [CI], 1.16-1.40]; p<0.001). Sequential adjustment for age, gender, race/ethnicity, body mass index (BMI), smoking, alcohol consumption, prevalent coronary heart disease (CHD), energy expenditure, and estimated glomerular filtration rate (based on cystatin C), moderately attenuated the hazard ratio for fracture (1.17; 95% CI, 1.05-1.31; p=0.006). In the cohort with BMD testing, total hip BMD was not significantly associated with CML levels. We conclude that increasing levels of CML are associated with hip fracture risk in older adults, independent of hip BMD. These results implicate AGE in the pathogenesis of hip fractures.

AB - Advanced glycation end products (AGE) in bone tissue are associated with impaired biomechanical properties and increased fracture risk. Here we examine whether serum levels of the AGE carboxy-methyl-lysine (CML) are associated with risk of hip fracture. We followed 3373 participants from the Cardiovascular Health Study (age 78 years; range, 68-102 years; 39.8% male) for a median of 9.22 years (range, 0.01-12.07 years). Rates of incident hip fracture were calculated by quartiles of baseline CML levels, and hazard ratios were adjusted for covariates associated with hip fracture risk. A subcohort of 1315 participants had bone mineral density (BMD) measurement. There were 348 hip fractures during follow-up, with incidence rates of hip fracture by CML quartiles of 0.94, 1.34, 1.18, and 1.69 per 100 participant-years. The unadjusted hazard ratio of hip fracture increased with each 1 SD increase (189ng/mL) of CML level (hazard ratio, 1.27; 95% confidence interval [CI], 1.16-1.40]; p<0.001). Sequential adjustment for age, gender, race/ethnicity, body mass index (BMI), smoking, alcohol consumption, prevalent coronary heart disease (CHD), energy expenditure, and estimated glomerular filtration rate (based on cystatin C), moderately attenuated the hazard ratio for fracture (1.17; 95% CI, 1.05-1.31; p=0.006). In the cohort with BMD testing, total hip BMD was not significantly associated with CML levels. We conclude that increasing levels of CML are associated with hip fracture risk in older adults, independent of hip BMD. These results implicate AGE in the pathogenesis of hip fractures.

KW - bone mineral density

KW - bone quality

KW - carboxy-methyl-lysine

KW - cardiovascular health study

KW - hip fracture risk

UR - http://www.scopus.com/inward/record.url?scp=84899109327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899109327&partnerID=8YFLogxK

U2 - 10.1002/jbmr.2123

DO - 10.1002/jbmr.2123

M3 - Article

C2 - 24877243

AN - SCOPUS:84899109327

VL - 29

SP - 1061

EP - 1066

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 5

ER -